RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow
出版年份 2013 全文链接
标题
RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow
作者
关键词
RelB, RelA, Cell survival, Proteasome inhibitor, CLL
出版物
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 92, Issue 1, Pages 77-92
出版商
Springer Nature
发表日期
2013-09-16
DOI
10.1007/s00109-013-1081-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival
- (2012) S. M. Ranuncolo et al. BLOOD
- Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- NF-κB and the link between inflammation and cancer
- (2012) Joseph A. DiDonato et al. IMMUNOLOGICAL REVIEWS
- Molecular pathogenesis of chronic lymphocytic leukemia
- (2012) Gianluca Gaidano et al. JOURNAL OF CLINICAL INVESTIGATION
- Stromal Endothelial Cells Establish a Bidirectional Crosstalk with Chronic Lymphocytic Leukemia Cells through the TNF-Related Factors BAFF, APRIL, and CD40L
- (2012) M. Cols et al. JOURNAL OF IMMUNOLOGY
- Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
- (2011) D. Rossi et al. BLOOD
- Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner
- (2011) Aisha Masood et al. BRITISH JOURNAL OF HAEMATOLOGY
- IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells
- (2011) M Coscia et al. LEUKEMIA
- Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines
- (2011) Feng Guo et al. MOLECULAR IMMUNOLOGY
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Prognostic Markers and Stratification of Chronic Lymphocytic Leukemia
- (2011) R. R. Furman Hematology-American Society of Hematology Education Program
- Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia
- (2011) J. A. Burger Hematology-American Society of Hematology Education Program
- RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells
- (2010) Aaron K. Holley et al. Annals of the New York Academy of Sciences
- The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia
- (2010) Y. Herishanu et al. BLOOD
- Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities
- (2010) N. Chiorazzi et al. BLOOD
- Classical and/or alternative NF- B pathway activation in multiple myeloma
- (2010) Y. N. Demchenko et al. BLOOD
- NF-κB as a therapeutic target in chronic lymphocytic leukemia
- (2010) Monica Lopez-Guerra et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The role of chemokines in B cell chronic lymphocytic leukaemia: pathophysiological aspects and clinical impact
- (2009) Percy Schröttner et al. ANNALS OF HEMATOLOGY
- Regulation and Function of NF-κB Transcription Factors in the Immune System
- (2009) Sivakumar Vallabhapurapu et al. Annual Review of Immunology
- TRAF3 in B cells: too much, too little, too bad
- (2009) P. Leif Bergsagel BLOOD
- Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
- (2009) A. V. Kurtova et al. BLOOD
- Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression
- (2009) Wei Ding et al. BRITISH JOURNAL OF HAEMATOLOGY
- RelB Enhances Prostate Cancer Growth: Implications for the Role of the Nuclear Factor- B Alternative Pathway in Tumorigenicity
- (2009) Y. Xu et al. CANCER RESEARCH
- Inhibition of RelB by 1,25-dihydroxyvitamin D3promotes sensitivity of breast cancer cells to radiation
- (2009) Nora D. Mineva et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia
- (2009) Saman Hewamana et al. JOURNAL OF CLINICAL ONCOLOGY
- RelB NF- B Represses Estrogen Receptor Expression via Induction of the Zinc Finger Protein Blimp1
- (2009) X. Wang et al. MOLECULAR AND CELLULAR BIOLOGY
- TRAF1 is involved in the classical NF-κB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells
- (2009) Feng Guo et al. MOLECULAR IMMUNOLOGY
- Lack of nuclear factor- B2/p100 causes a RelB-dependent block in early B lymphopoiesis
- (2008) F. Guo et al. BLOOD
- The NF- B subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
- (2008) S. Hewamana et al. BLOOD
- AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance
- (2008) K. Balakrishnan et al. BLOOD
- BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells
- (2008) P Pérez-Galán et al. LEUKEMIA
- RelB-Dependent Stromal Cells Promote T-Cell Leukemogenesis
- (2008) Nuno R. dos Santos et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now